News

  • Bone marrow link: Amsterdam UMC study suggests anti‑inflammatory effects of semaglutide
    Bone marrow link: Amsterdam UMC study suggests anti‑inflammatory effects of semaglutide Semaglutide, the GLP-1 receptor agonist known as Ozempic and Wegovy, is associated with fewer inflammatory monocytes and reduced inflammatory activity in the bone marrow of people with type 2 diabetes. Researchers from Amsterdam UMC and Amsterdam Cardiovascular Sciences report this in an exploratory first-in-human study published in the European Heart Journal, offering a potential explanation for the cardiovascular benefits of GLP-1 therapies.
  • World heart day: Detecting microvascular disease with a CT scan
    World heart day: Detecting microvascular disease with a CT scan On World Heart Day, ACS highlights the ANOCA-CT study by Bettine van Willigen and Fabienne Vervaat: detecting microvascular disease using solely the CT scan.
  • MS-patients that follow a lifestyle program have less symptoms
    MS-patients that follow a lifestyle program have less symptoms Two years after the start of the lifestyle program 'Leef! met MS' participants with multiple sclerosis (MS) experience less symptoms than before, both fysically and mentally. Additionally, their lifestyle remained healthier, even after the intensive guidance stopped. This has been reported in a study from Amsterdam UMC with 659 participants with MS.